Federal contract award
75FCMC22F0007
EVALUATION OF THE INTRAVENOUS IMMUNE GLOBULIN DEMONSTRATION: THE PURPOSE OF THIS REQUIREMENT IS TO SECURE A QUALIFIED VENDOR TO DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION THAT INFORMS THE INTERMEDIATE AND FINAL REPORT TO CONGRESS (RTC). THIS EFFO
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | OFC OF ACQUISITION AND GRANTS MGMT |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 47QRAA21D002Y |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.8M |
| Current contract value | $1.8M |
| Potential contract value / ceiling | $1.8M |
| Start date | Dec 22, 2021 |
| Current end date | Jun 21, 2025 |
| Potential end date | Jun 21, 2025 |
| Latest award activity | Apr 17, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 17, 2025 | P00007 | $0 | EVALUATION OF THE INTRAVENOUS IMMUNE GLOBULIN DEMONSTRATION: THE PURPOSE OF THIS REQUIREMENT IS TO SECURE A QUALIFIED VENDOR TO DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION THAT INFORMS THE INTERMEDIATE AND FINAL REPORT TO CONGRESS (RTC). THIS EFFO |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.